Elisa Seubert
Dr. med.
Elisa Seubert
  • Assistenzärztin
Arbeitsbereich

Kontakt

Standort

O24
Sprachen
Deutsch (Muttersprache)
Englisch
Französisch

Fachgebiete

Publikationen

2026

SHORTER TREATMENT, FASTER DISCHARGE. THE IMPACT OF DAY 14 ASSESSMENT IN AML PATIENTS ON AZA-VEN: A SINGLE CENTER EXPERIENCE.
Klingler F, Seubert E, Wienecke C, Pfaff S, Holzapfel A, Kruse F, Bokemeyer C, Stübig T, Fiedler W, Westendorf F
HEMASPHERE. 2026;2026(10):.

REAL-WORLD INSIGHTS INTO SALVAGE CHEMOTHERAPY FOR FIT FAVORABLE-RISK AML PATIENTS AT FIRST RELAPSE
Seubert E, Klingler F, Ayuk F, Bokemeyer C, Fiedler W, Westendorf F
HEMASPHERE. 2026.

2025

A diagnostic pitfall: Therapy-related acute promyelocytic leukemia mimicking mixed-phenotype acute leukemia
Seubert E, Ullrich F, Kruppa M, Küster L, Schaefers C, Klingler F, Bokemeyer C, Fiedler W, Stübig T, Westendorf F
BLOOD. 2025;146(Supplement 1):6936-6936.

2024

Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction
Marius W, Leticia O, Friedrich K, Stephan M, Louisa H, Tabea S, Elisa S, Pauline W, Yi D, Qi M, Barbara S, Carsten B, Walter F, Jasmin W, Franziska B
ONCOIMMUNOLOGY. 2024;13(1):2346359.

2022

TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis
Brauneck F, Fischer B, Witt M, Muschhammer J, Oelrich J, da Costa Avelar P, Tsoka S, Bullinger L, Seubert E, Smit D, Bokemeyer C, Ackermann C, Wellbrock J, Haag F, Fiedler W
J IMMUNOTHER CANCER. 2022;10(12):.

2021

Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML
Brauneck F, Seubert E, Wellbrock J, Schulze Zur Wiesch J, Duan Y, Magnus T, Bokemeyer C, Koch-Nolte F, Menzel S, Fiedler W
INT J MOL SCI. 2021;22(23):.

Letzte Aktualisierung aus dem FIS: 17.11.2026 - 03:29 Uhr